Brugada Syndrome (disorder)
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
The sodium channel gene SCN5A and potassium channel genes KCNQ1 and KCNH2 have been widely reported to be genetic risk factors for arrhythmia including Brugada syndrome and long QT syndrome (LQTS).
|
31751991 |
2020 |
Brugada Syndrome (disorder)
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Long QT type 1 (gene, KCNQ1) and CPVT (gene, RyR2) typically present with cardiac events (ie syncope or cardiac arrest) during or immediately after exercise in young males; long QT type 2 (gene, KCNH2) after startle or during the night in adult females-particularly early post-partum, and long QT type 3 and Brugada syndrome (gene, SCN5A) during the night in young adult males.
|
30389366 |
2019 |
Brugada Syndrome (disorder)
|
0.450 |
Biomarker
|
disease |
CLINGEN |
Additional next generation sequencing analyses revealed the p.R25W mutation in KCNH2 gene in SCN5A-negative BrS patients.
|
25626866 |
2015 |
Brugada Syndrome (disorder)
|
0.450 |
Biomarker
|
disease |
CLINGEN |
We identified 4 KCNH2 mutations, T152I, R164C, W927G, and R1135H, in 236 consecutive probands with BrS or Brugada-like ECG.
|
24400717 |
2014 |
Brugada Syndrome (disorder)
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
All KCNH2 mutations that we identified in probands with BrS exerted gain-of-function effects on I(Kr) channels, which may partially explain the ECG findings in our patients.
|
24400717 |
2014 |
Brugada Syndrome (disorder)
|
0.450 |
Biomarker
|
disease |
BEFREE |
Postmortem molecular analysis of KCNQ1, KCNH2, KCNE1 and KCNE2 genes in sudden unexplained nocturnal death syndrome in the Chinese Han population.
|
23890619 |
2013 |
Brugada Syndrome (disorder)
|
0.450 |
GeneticVariation
|
disease |
CLINVAR |
Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome.
|
22949429 |
2012 |
Brugada Syndrome (disorder)
|
0.450 |
Biomarker
|
disease |
CLINGEN |
Rescue of aberrant gating by a genetically encoded PAS (Per-Arnt-Sim) domain in several long QT syndrome mutant human ether-á-go-go-related gene potassium channels.
|
21536673 |
2011 |
Brugada Syndrome (disorder)
|
0.450 |
Biomarker
|
disease |
CLINGEN |
A novel KCNH2 mutation as a modifier for short QT interval.
|
18692916 |
2009 |
Brugada Syndrome (disorder)
|
0.450 |
GeneticVariation
|
disease |
CLINVAR |
Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
|
15840476 |
2005 |
Brugada Syndrome (disorder)
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome.
|
16043162 |
2005 |
Brugada Syndrome (disorder)
|
0.450 |
Biomarker
|
disease |
CLINGEN |
Role of sequence variations in the human ether-a-go-go-related gene (HERG, KCNH2) in the Brugada syndrome.
|
16043162 |
2005 |
Brugada Syndrome (disorder)
|
0.450 |
Biomarker
|
disease |
CLINGEN |
Selective knockout of mouse ERG1 B potassium channel eliminates I(Kr) in adult ventricular myocytes and elicits episodes of abrupt sinus bradycardia.
|
12612061 |
2003 |
Brugada Syndrome (disorder)
|
0.450 |
GeneticVariation
|
disease |
CLINVAR |
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.
|
11997281 |
2002 |